Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate...

por Prawjaeng, Juthamas, Leelahavarong, Pattara, Budtarad, Nuttakarn, Pilasant, Songyot, Chanjam, Chonticha, Katchamart, Wanruchada, Narongroeknawin, Pongthorn, Kitumnuaypong, Tasanee
Publicado 2023

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis

por Songpatanasilp, T., Sritara, C., Kittisomprayoonkul, W., Chaiumnuay, S., Nimitphong, H., Charatcharoenwitthaya, N., Pongchaiyakul, C., Namwongphrom, S., Kitumnuaypong, T., Srikam, W., Dajpratham, P., Kuptniratsaikul, V., Jaisamrarn, U., Tachatraisak, K., Rojanasthien, S., Damrongwanich, P., Wajanavisit, W., Pongprapai, S., Ongphiphadhanakul, B., Taechakraichana, N.
Publicado 2016